Detalhe da pesquisa
1.
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.
PLoS One
; 16(2): e0246540, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33571237
2.
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: a prospective cohort study of five target groups
PloS One, v. 16, n. 2, e0246540, fev. 2021
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-3536
3.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect. Dis.
; 2020.
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: but-ib17572
4.
Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect Dis, v. 20, n. 7, p. 839-850, mar. 2020
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-2991